Phosphorylation of DARPP-32 is regulated by GABA in rat striatum and substantia nigra.
In the medium-sized spiny neurons of the striatonigral pathway, a cascade of events involving the activation of dopamine D1 receptors, an increase in cyclic AMP, and activation of cyclic AMP-dependent protein kinase causes the phosphorylation of DARPP-32 on Thr34, converting DARPP-32 into a powerful inhibitor of protein phosphatase-1. In the present study, the incubation of striatal or substantia nigra slices with GABA also increased the phosphorylation of DARPP-32 on Thr34. GABA did not significantly increase cyclic AMP levels in slices. The phosphorylation of DARPP-32 by GABA was blocked in both brain regions by pretreatment of slices with the GABAA receptor antagonist, bicuculline, but not with the GABAB receptor antagonist, phaclofen. Moreover, the threonine phosphorylation of DARPP-32 produced by maximally effective doses of either forskolin (in striatum) or L-3,4-dihydroxyphenylalanine (in substantia nigra) was increased further by GABA. The data are consistent with a model in which GABA increases the phosphorylation state of DARPP-32 by inhibiting dephosphorylation of the protein by the calcium/calmodulin-dependent protein phosphatase, calcineurin.
Snyder
G L
GL
Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, New York 10021.
Fisone
G
G
Greengard
P
P
D000818:Animals; D001418:Baclofen / Q000031:analogs & derivatives / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D003342:Corpus Striatum / Q000737:chemistry / Q000378:metabolism*; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D018756:GABA Antagonists / Q000494:pharmacology; D008297:Male; D009419:Nerve Tissue Proteins / Q000032:analysis / Q000378:metabolism*; D010750:Phosphoproteins; D010766:Phosphorylation / Q000187:drug effects; D011863:Radioimmunoassay; D051381:Rats; D017207:Rats, Sprague-Dawley; D018079:Receptors, GABA / Q000032:analysis / Q000502:physiology; D013378:Substantia Nigra / Q000737:chemistry / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology / Q000502:physiology*
D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D018756:GABA Antagonists; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; D018079:Receptors, GABA; C052329:phaclofen; D005576:Colforsin; D005680:gamma-Aminobutyric Acid; D000242:Cyclic AMP; D001418:Baclofen